Back
Integra Lifesciences Holdings Vs. Perspective Therapeutics Industry Stock Comparison
Sell
16
IART
Integra Lifesciences Holdings
Last Price:
17.02
Seasonality Move:
-0.2%
Sell
30
CATX
Perspective Therapeutics
Last Price:
13.38
Seasonality Move:
-6.23%
Sell
16
Integra Lifesciences Holdings (IART)
is a Sell
Is Integra Lifesciences Holdings a Buy, Sell or Hold?
- The current Integra Lifesciences Holdings [IART] share price is $16.96. The Score for IART is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- IART is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $13.21. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IART Stock Price Chart
What is Integra Lifesciences Holdings's stock price today?
-
The Integra Lifesciences Holdings share price today is $16.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IART is experiencing slight selling pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $13.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight buying pressure.
IART Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.89 | Sell |
| Relative Strength Index (14 RSI): | 32.77 | Sell |
| Chaikin Money Flow: | -129156 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.02 - 18.98) | Sell |
| Bollinger Bands (100): | (19.76 - 30.12) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 47.28 | Sell |
| Chaikin Money Flow: | 275341 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.66 - 15.32) | Sell |
| Bollinger Bands (100): | (11.43 - 15.07) | Sell |
IART Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.54 | Sell |
| 20-day SMA: | 17.56 | Sell |
| 50-day SMA: | 20.43 | Sell |
| 200-day SMA: | 31.19 | Sell |
| 8-day EMA: | 17.46 | Sell |
| 20-day EMA: | 18.02 | Sell |
| 50-day EMA: | 20.52 | Sell |
| 200-day EMA: | 29.17 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.71 | Buy |
| 20-day SMA: | 13.68 | Sell |
| 50-day SMA: | 13.77 | Sell |
| 200-day SMA: | 11.78 | Buy |
| 8-day EMA: | 12.99 | Buy |
| 20-day EMA: | 13.39 | Sell |
| 50-day EMA: | 13.55 | Sell |
| 200-day EMA: | 11.62 | Buy |
Integra Lifesciences Holdings Earnings Growth & IART Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.66 per share, and an increase next year of $0.06 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
Integra Lifesciences Holdings Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||